Correlation Between Vericel Corp and VBI Vaccines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and VBI Vaccines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and VBI Vaccines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and VBI Vaccines, you can compare the effects of market volatilities on Vericel Corp and VBI Vaccines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of VBI Vaccines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and VBI Vaccines.

Diversification Opportunities for Vericel Corp and VBI Vaccines

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Vericel and VBI is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and VBI Vaccines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VBI Vaccines and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with VBI Vaccines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VBI Vaccines has no effect on the direction of Vericel Corp i.e., Vericel Corp and VBI Vaccines go up and down completely randomly.

Pair Corralation between Vericel Corp and VBI Vaccines

Given the investment horizon of 90 days Vericel Corp Ord is expected to under-perform the VBI Vaccines. But the stock apears to be less risky and, when comparing its historical volatility, Vericel Corp Ord is 4.06 times less risky than VBI Vaccines. The stock trades about -0.06 of its potential returns per unit of risk. The VBI Vaccines is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  57.00  in VBI Vaccines on January 25, 2024 and sell it today you would earn a total of  2.00  from holding VBI Vaccines or generate 3.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  VBI Vaccines

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Vericel Corp may actually be approaching a critical reversion point that can send shares even higher in May 2024.
VBI Vaccines 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in VBI Vaccines are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward indicators, VBI Vaccines may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Vericel Corp and VBI Vaccines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and VBI Vaccines

The main advantage of trading using opposite Vericel Corp and VBI Vaccines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, VBI Vaccines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will offset losses from the drop in VBI Vaccines' long position.
The idea behind Vericel Corp Ord and VBI Vaccines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
CEOs Directory
Screen CEOs from public companies around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data